Medicaid Drug Review, Utilization, Good Governance Improvement Act: report (to accompany H.R. 5799) (including cost estimate of the Congressional Budget Office).
(eGov Doc)
Fraud -- United States -- Prevention -- Government policy.
Medicaid fraud -- Prevention.
Medicare -- Cost control.
Medicare -- Law and legislation.
Medicare beneficiaries -- Identification.
Medicare fraud -- Prevention.
Opioid abuse -- Treatment -- United States -- Costs.
United States. -- Social Security Act.
Notes
United States. Congress. House. Committee on Energy and Commerce. (2018). Medicaid Drug Review, Utilization, Good Governance Improvement Act: report (to accompany H.R. 5799) (including cost estimate of the Congressional Budget Office). [Washington, D.C.], [U.S. Government Publishing Office].
Chicago / Turabian - Author Date Citation (style guide)United States. Congress. House. Committee on Energy and Commerce. 2018. Medicaid Drug Review, Utilization, Good Governance Improvement Act: Report (to Accompany H.R. 5799) (including Cost Estimate of the Congressional Budget Office). [Washington, D.C.], [U.S. Government Publishing Office].
Chicago / Turabian - Humanities Citation (style guide)United States. Congress. House. Committee on Energy and Commerce, Medicaid Drug Review, Utilization, Good Governance Improvement Act: Report (to Accompany H.R. 5799) (including Cost Estimate of the Congressional Budget Office). [Washington, D.C.], [U.S. Government Publishing Office], 2018.
MLA Citation (style guide)United States. Congress. House. Committee on Energy and Commerce. Medicaid Drug Review, Utilization, Good Governance Improvement Act: Report (to Accompany H.R. 5799) (including Cost Estimate of the Congressional Budget Office). [Washington, D.C.], [U.S. Government Publishing Office], 2018.
Record Information
Last Sierra Extract Time | Apr 15, 2024 07:08:28 PM |
---|---|
Last File Modification Time | Apr 15, 2024 07:08:48 PM |
Last Grouped Work Modification Time | Apr 15, 2024 07:08:34 PM |
MARC Record
LEADER | 02350cam 2200505 i 4500 | ||
---|---|---|---|
001 | on1041706883 | ||
003 | OCoLC | ||
005 | 20181109130329.0 | ||
006 | m o d f | ||
007 | cr bn||||a|||| | ||
008 | 180622s2018 dcu ob f000 0 eng c | ||
040 | |a GPO|b eng|e rda|e pn|c GPO|d GPO|d IUL|d MERUC|d OCLCF|d INT|d GPO|d MvI | ||
042 | |a pcc | ||
043 | |a n-us--- | ||
050 | 4 | |a KF32|b .E55 2018j | |
074 | |a 1008-I (online) | ||
086 | 0 | |a Y 1.1/8:115-728 | |
110 | 1 | |a United States.|b Congress.|b House.|b Committee on Energy and Commerce,|e author. | |
245 | 1 | 0 | |a Medicaid Drug Review, Utilization, Good Governance Improvement Act :|b report (to accompany H.R. 5799) (including cost estimate of the Congressional Budget Office). |
264 | 1 | |a [Washington, D.C.] :|b [U.S. Government Publishing Office],|c [2018] | |
300 | |a 1 online resource (147 pages). | ||
336 | |a text|b txt|2 rdacontent | ||
337 | |a computer|b c|2 rdamedia | ||
338 | |a online resource|b cr|2 rdacarrier | ||
490 | 1 | |a Report / 115th Congress, 2d session, House of Representatives ;|v 115-728 | |
500 | |a "June 12, 2018." | ||
504 | |a Includes bibliographical references. | ||
588 | |a Description based on online resource, PDF version; title from caption (Govinfo, viewed June 21, 2018). | ||
610 | 1 | 0 | |a United States.|t Social Security Act. |
650 | 0 | |a Medicare beneficiaries|x Identification. | |
650 | 0 | |a Drugs|z United States|x Safety measures. | |
650 | 0 | |a Medicare fraud|x Prevention. | |
650 | 0 | |a Medicaid fraud|x Prevention. | |
650 | 0 | |a Fraud|z United States|x Prevention|x Government policy. | |
650 | 0 | |a Opioid abuse|x Treatment|z United States|x Costs. | |
650 | 0 | |a Medicare|x Cost control. | |
650 | 0 | |a Medicare|x Law and legislation. | |
655 | 7 | |a Legislative materials.|2 lcgft | |
776 | 0 | 8 | |i Microfiche version:|a United States. Congress. House. Committee on Energy and Commerce.|t Medicaid Drug Review, Utilization, Good Governance Improvement Act|w (OCoLC)1062362734 |
776 | 0 | 8 | |i Print version:|a United States. Congress. House. Committee on Energy and Commerce.|t Medicaid Drug Review, Utilization, Good Governance Improvement Act|w (OCoLC)1041708255 |
810 | 1 | |a United States.|b Congress.|b House.|t Report ;|v 115-728. | |
856 | 4 | 0 | |u https://purl.fdlp.gov/GPO/gpo93921 |
901 | |a eGov Doc | ||
907 | |a .b25902428 | ||
998 | |e l|d 7 |f eng|a spl |